Status: current, Defined. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4825531000168117 | Sunlenca (lenacapavir 463.5 mg / 1.5 mL) injection, 2 x 1.5 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4825541000168114 | Sunlenca 463.5 mg/1.5 mL injection, 2 x 1.5 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sunlenca 463.5 mg/1.5 mL injection, 2 x 1.5 mL vials | Is a | lenacapavir 463.5 mg/1.5 mL injection, 2 x 1.5 mL vials | true | Inferred relationship | Some | ||
| Sunlenca 463.5 mg/1.5 mL injection, 2 x 1.5 mL vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| Sunlenca 463.5 mg/1.5 mL injection, 2 x 1.5 mL vials | has TP | Sunlenca | true | Inferred relationship | Some | ||
| Sunlenca 463.5 mg/1.5 mL injection, 2 x 1.5 mL vials | has TPUU | Sunlenca 463.5 mg/1.5 mL injection, 1.5 mL vial | true | Inferred relationship | Some | 2129294112 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sunlenca 463.5 mg/1.5 mL injection, 2 x 1.5 mL vials | Is a | True | Sunlenca 463.5 mg/1.5 mL injection, 2 x 1.5 mL vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR